The U.S. healthcare industry is currently experiencing a decline in hospital mergers and acquisitions due to the ongoing impact of the COVID-19 pandemic.

Health systems are focusing on operational efficiency and are increasingly choosing partnerships or sales agreements to effectively serve local communities.

In this challenging environment, conducting thorough due diligence is crucial for healthcare organizations considering mergers. This careful assessment is necessary to mitigate potential financial and regulatory risks that may arise during the merger process.

As the situation continues to evolve, stakeholders are advised to make strategic decisions with caution in order to navigate these unprecedented times.